Cytovene IV 500 lyophilized powder for injectable solution

Cytovene IV (Genentech), manufactured drug form of Ganciclovir sodium, 500mg/10mL ganciclovir sodium lyophilized powder for injectable solution, NDC 0004-6940

Available in:

NDC Product ID:

  • 0004-6940

Manufacturer:

Manufactured drug form

Generic drug:

  • No

Label date:

  • Aug 3, 2010

Label sections:

Section name Section URI Prominent warning Highlight text Section LOINC code
  • Spl Unclassified Section
  • No
  • 42229-5
  • Warning
  • Yes
  • THE CLINICAL TOXICITY OF CYTOVENE-IV INCLUDES GRANULOCYTOPENIA, ANEMIA AND THROMBOCYTOPENIA. IN ANIMAL STUDIES GANCICLOVIR WAS CARCINOGENIC, TERATOGENIC AND CAUSED ASPERMATOGENESIS. CYTOVENE-IV IS INDICATED FOR USE ONLY IN THE TREATMENT OF CYTOMEGALOVIRUS (CMV) RETINITIS IN IMMUNOCOMPROMISED PATIENTS AND FOR THE PREVENTION OF CMV DISEASE IN TRANSPLANT PATIENTS AT RISK FOR CMV DISEASE (see INDICATIONS AND USAGE).
  • 34066-1
  • Description
  • No
  • 34089-3
  • Virology
  • No
  • 42229-5
  • Clinical Pharmacology
  • No
  • 34090-1
  • Indications And Usage
  • No
  • 34067-9
  • Clinical Trials
  • No
  • 34092-7
  • Contraindications
  • No
  • 34070-3
  • Warnings
  • No
  • 34071-1
  • Precautions
  • No
  • 42232-9
View entire collection »

Discontinued:

  • No

Marketing start date:

  • Jun 23, 1989

FDA application number:

  • NDA019661
top ↑

We can also tell you Cytovene IV 500 lyophilized powder for injectable solution is a…

If you know more about Cytovene IV 500 lyophilized powder for injectable solution, you can add more facts here »

You can help improve this topic by adding more facts here

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!